Statement Of Financial Position [Abstract]

Egetis Therapeutics - Filing #701621

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Right-of-use assets	4 088 SEK	—	—	—	—	4 666 SEK	—	—	—	—	—	—	—	—	—
Other non-current financial assets	785,000 SEK	—	—	—	—	– SEK	—	—	—	—	—	—	—	—	—
Non-current assets	416 366 SEK	—	—	—	—	417 130 SEK	—	—	—	—	—	—	—	—	—
Current assets [abstract]
Current inventories	694,000 SEK	—	—	—	—	3 138 SEK	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	143 965 SEK	—	—	—	—	287 850 SEK	—	—	—	—	—	—	255 101 SEK	—	—
Current assets	152 902 SEK	—	—	—	—	299 871 SEK	—	—	—	—	—	—	—	—	—
Assets	569 269 SEK	—	—	—	—	717 000 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	8 688 SEK	—	—	—	—	8 688 SEK	—	—	—	—	—	—	—	—	—
Retained earnings	745 792 SEK	—	—	—	—	641 250 SEK	—	—	—	—	—	—	—	—	—
Other reserves	1 305 SEK	—	—	—	—	448,000 SEK	—	—	—	—	—	—	—	—	—
Equity	527 039 SEK	745 792 SEK	1 305 SEK	1 262 837 SEK	8 688 SEK	630 723 SEK	8 688 SEK	641 250 SEK	448,000 SEK	1 262 837 SEK	463 220 SEK	– SEK	244 876 SEK	705 278 SEK	2 818 SEK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	3 060 SEK	—	—	—	—	16 135 SEK	—	—	—	—	—	—	—	—	—
Current liabilities [abstract]
Current liabilities	39 170 SEK	—	—	—	—	70 141 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities	569 269 SEK	—	—	—	—	717 000 SEK	—	—	—	—	—	—	—	—	—